Cetlalimumab: Difference between revisions

Jump to navigation Jump to search
WikiBot (talk | contribs)
m Protected "Cetlalimumab": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))
 
WikiBot (talk | contribs)
m Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)
 
Line 20: Line 20:
}}
}}
{{SI}}
{{SI}}
{{EH}}
 


==Overview==
==Overview==
Line 26: Line 26:


{{humanmonoclonals}}
{{humanmonoclonals}}
{{SIB}}
 
[[Category:Monoclonal antibodies]]
[[Category:Monoclonal antibodies]]
[[Category:Cancer treatments]]
[[Category:Cancer treatments]]
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WS}}
{{WS}}

Latest revision as of 23:42, 8 August 2012

Template:Drugbox-mab

WikiDoc Resources for Cetlalimumab

Articles

Most recent articles on Cetlalimumab

Most cited articles on Cetlalimumab

Review articles on Cetlalimumab

Articles on Cetlalimumab in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Cetlalimumab

Images of Cetlalimumab

Photos of Cetlalimumab

Podcasts & MP3s on Cetlalimumab

Videos on Cetlalimumab

Evidence Based Medicine

Cochrane Collaboration on Cetlalimumab

Bandolier on Cetlalimumab

TRIP on Cetlalimumab

Clinical Trials

Ongoing Trials on Cetlalimumab at Clinical Trials.gov

Trial results on Cetlalimumab

Clinical Trials on Cetlalimumab at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Cetlalimumab

NICE Guidance on Cetlalimumab

NHS PRODIGY Guidance

FDA on Cetlalimumab

CDC on Cetlalimumab

Books

Books on Cetlalimumab

News

Cetlalimumab in the news

Be alerted to news on Cetlalimumab

News trends on Cetlalimumab

Commentary

Blogs on Cetlalimumab

Definitions

Definitions of Cetlalimumab

Patient Resources / Community

Patient resources on Cetlalimumab

Discussion groups on Cetlalimumab

Patient Handouts on Cetlalimumab

Directions to Hospitals Treating Cetlalimumab

Risk calculators and risk factors for Cetlalimumab

Healthcare Provider Resources

Symptoms of Cetlalimumab

Causes & Risk Factors for Cetlalimumab

Diagnostic studies for Cetlalimumab

Treatment of Cetlalimumab

Continuing Medical Education (CME)

CME Programs on Cetlalimumab

International

Cetlalimumab en Espanol

Cetlalimumab en Francais

Business

Cetlalimumab in the Marketplace

Patents on Cetlalimumab

Experimental / Informatics

List of terms related to Cetlalimumab


Overview

Cetlalimumab is a human monoclonal antibody which is used to treat cancer.

Template:Humanmonoclonals

Template:WS